Cataplexy Narcolepsy
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy (NCT04923594) | NLS Pharmaceutics | 2021-09-13 |
| Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT) (NCT03881852) | Axsome Therapeutics, Inc. | 2019-04-05 |
Track Cataplexy Narcolepsy automatically
Every clearance here is in the API, with alerts when new ones post.